Drawing for NEULOGIQ

USPTO serial 79411918

NEULOGIQ

Reviewed by CopyMark Law Group

Reg. 7781412Status 700Registered
Filing date
Status date
Registration date
May 6, 2025
Examiner
GREENE, JOSEPH A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NEULOGIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven J. Solomon

Steven J. Solomon Tucker Ellis LLP950 Main Avenue, Suite 1100Cleveland, OH 44113United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software and computer programs for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; electronic scientific laboratory research apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; downloadable computer games software; downloadable computer software and applications for the provision of medical and pharmaceutical information and reports; downloadable computer software and applications for storing, relaying, tracking, measuring and displaying the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological diseases, as well as brain injury, insult and mental illness in human beings and other animals; wireless headsets for smartphones and tablet computers; wireless headsets for playing video games, computer games and games downloadable on mobile electronic devices; sensors and detectors for scientific use to be worn by a human to gather human biometric data; downloadable computer software and applications for neuroimaging for use in the diagnosis and treatment of medical conditions including neurological disease, brain injury, and mental illness; parts and fittings for the aforesaid goods.ACTIVE—
010Medical apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; medical apparatus and instruments, namely, sensors to be worn by a human for storing, relaying, tracking, measuring and displaying human cognitive and biometric data; medical apparatus and instruments for storing, relaying, tracking, and measuring the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological diseases, as well as brain injury or insult and mental illness in human beings and other animals, and for displaying associated neurological and psychiatric data; medical diagnostic and testing apparatus and instruments for detecting neurological diseases, brain injuries and mental illnesses; medical apparatus and instruments, namely, electroencephalogram (EEG) for the therapeutic and medical treatment of disease including neurological disease, brain injury, and mental illness; parts and fittings for the aforesaid goods.ACTIVE—
042Design and development of computer software and computer programs for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; product development, namely, design and development of electronic apparatus and instruments for assessing, monitoring, checking and tracking neurological states and conditions, cognitive performance, cognitive health, and mechanisms of and responses to therapies; design and development of computer games software; design and development of computer software and mobile and tablet application software for the provision of medical and pharmaceutical information and reports; design and development of computer software and mobile and tablet application software for storing, relaying, tracking, measuring and displaying the onset, presence and progression of neurodegenerative, neuropsychiatric, neurodevelopmental, neuromuscular and other neurological disease, brain injury or insult and mental illness in human beings and other animals; product development, namely, design and development of wireless headsets; product development, namely, design and development of wireless headsets for playing video games, computer games and games downloadable on mobile electronic devices; product development, namely, design and development of sensors and detectors for scientific use to be worn by a human to gather biometric data; design and development of computer software and mobile and tablet application software for the diagnosis and treatment of medical conditions including neurological disease, brain injury, and mental illness; design and development of computer software and mobile and tablet application software for therapeutic and medical treatment of disease including neurological disease, brain injury, and mental illness; information, advisory and consultancy services in relation to the aforesaid services.ACTIVE—
044Medical services; medical screening and testing services; medical evaluation services for neurological diseases; medical examination being health assessment services; neurological and cognitive testing and analysis for medical purposes; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical advisory services, namely, measurement and prediction of response to medical treatments; human healthcare services, namely, neurology and psychiatric healthcare services; medical treatment services of neurological diseases, brain injuries and mental illnesses; medical diagnostic reporting services, namely, preparation of reports relating to medical matters; information, advisory and consultancy services in relation to the aforesaid services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 28, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 11, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 11, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 29, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 25, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 5, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 5, 2025FIMPFINAL DISPOSITION PROCESSED—
Aug 7, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 6, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 6, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 18, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 18, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 12, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 26, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2025RFNTREFUSAL PROCESSED BY IB—
Dec 31, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 31, 2024RFRRREFUSAL PROCESSED BY MPU—
Dec 15, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 14, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2024DOCKASSIGNED TO EXAMINER—
Dec 13, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 12, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance